SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
08-Aug-24 4:33 PM View: | Vor Biopharma Inc. (VOR) | 06-Aug-24 | Payment of Exercise | 999 | $0.87 | $869.13 | (1%) 94.92K to 93.92K | |
05-Aug-24 4:15 PM View: | Vor Biopharma Inc. (VOR) | 01-Aug-24 | Payment of Exercise | 1,146 | $0.94 | $1,077.24 | (1%) 96.06K to 94.92K | |
04-Jun-24 6:09 PM View: | Vor Biopharma Inc. (VOR) | 03-Jun-24 | Sale (Planned) | 14,645 | $1.39 | $20,356.50 | (13%) 110.71K to 96.06K | |
07-May-24 4:15 PM View: | Vor Biopharma Inc. (VOR) | 06-May-24 | Payment of Exercise | 999 | $1.75 | $1,748.25 | (< 1%) 111.71K to 110.71K | |
03-May-24 4:15 PM View: | Vor Biopharma Inc. (VOR) | 01-May-24 | Payment of Exercise | 1,146 | $1.77 | $2,028.42 | (1%) 112.85K to 111.71K | |
08-Feb-24 5:10 PM View: | Vor Biopharma Inc. (VOR) | 06-Feb-24 | Payment of Exercise | 1,180 | $2.32 | $2,737.60 | (1%) 114.03K to 112.85K | |
31-Jan-24 7:38 PM View: | Vor Biopharma Inc. (VOR) | 29-Jan-24 | Grant | 62,500 | -- | -- | 121% 51.53K to 114.03K | |
08-Nov-23 4:10 PM View: | Vor Biopharma Inc. (VOR) | 06-Nov-23 | Payment of Exercise | 999 | $1.82 | $1,818.18 | (2%) 52.53K to 51.53K | |
09-Aug-23 4:31 PM View: | Vor Biopharma Inc. (VOR) | 07-Aug-23 | Payment of Exercise | 999 | $2.67 | $2,667.33 | (2%) 53.53K to 52.53K | |
10-May-23 4:14 PM View: | Vor Biopharma Inc. (VOR) | 08-May-23 | Payment of Exercise | 969 | $4.14 | $4,011.66 | (2%) 54.5K to 53.53K | |
08-Feb-23 4:23 PM View: | Vor Biopharma Inc. (VOR) | 06-Feb-23 | Grant | 54,500 | -- | -- | 100% 0 to 54.5K | |
07-Jun-22 5:00 PM View: | Aprea Therapeutics, Inc. (APRE) | 03-Jun-22 | Payment of Exercise | 32,667 | $0.81 | $26,296.90 | (36%) 90.06K to 57.39K | |
14-Mar-22 5:01 PM View: | Aprea Therapeutics, Inc. (APRE) | 10-Mar-22 | Grant | 42,900 | -- | -- | 91% 47.16K to 90.06K | |
01-Mar-22 5:01 PM View: | Aprea Therapeutics, Inc. (APRE) | 28-Feb-22 | Sale (Planned) | 36,000 | $1.73 | $62,280.00 | (43%) 83.33K to 47.33K | |
20-Sep-21 5:29 PM View: | Aprea Therapeutics, Inc. (APRE) | 16-Sep-21 | Market Sale (Planned) | 15,968 | $4.68 | $74,730.20 | (16%) 99.3K to 83.33K | (8%) |
27-Aug-21 5:00 PM View: | Aprea Therapeutics, Inc. (APRE) | 25-Aug-21 | Payment of Exercise | 9,032 | $3.98 | $35,947.40 | (8%) 108.33K to 99.3K | (5%) |
01-Mar-21 7:12 PM View: | Aprea Therapeutics, Inc. (APRE) | 25-Feb-21 | Grant | 108,000 | -- | -- | 27000% 0.4K to 108.4K | |
07-Oct-19 7:18 PM View: | Aprea Therapeutics, Inc. (APRE) | 07-Oct-19 | Purchase | 400 | $15.00 | $6,000.00 | 100% 0 to 0.4K |